Results 21 to 30 of about 2,532,507 (339)

Cytoreductive Surgery and Peritonectomy Procedures [PDF]

Indian Journal of Surgical Oncology, 2016
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has become widely accepted as an effective method of treating peritoneal metastases (PM) from various cancers. CRS performed with the goal of removing all the macroscopic disease and comprises of peritonectomy procedures and visceral resections.
Aditi Bhatt, Sanket Mehta, Olivier Glehen   +2 more
openaire   +3 more sources

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study

BMC Cancer, 2022
Background Ureteral reconstruction is required after surgical resection of the tumor invading the urinary tract in ovarian cancer with low incidence.
Ji Hyun Kim, Dong-eun Lee, Hyeong In Ha, Jae Young Jung, Sung Han Kim, Hyung Ho Lee, Ho Kyung Seo, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim   +10 more
doaj   +1 more source

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis

Journal of Clinical Oncology, 2021
PURPOSE The survival impact of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer was studied. METHODS We identified published studies from 1983 to 2021 following our inclusion criteria from MEDLINE, EMBASE, and ...
M. Baek, E. Park, H. I. Ha, S. Park, M. Lim, C. Fotopoulou, R. Bristow   +6 more
semanticscholar   +1 more source

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review

Current Oncology, 2023
Desmoplastic small round cell tumor is a very rare and highly aggressive soft tissue sarcoma, usually presenting with multiple intra-abdominal tumors in young males. Patients present with advanced disease and the overall survival is dismal.
Sophie J. M. Reijers, Caroline C. H. Siew, Niels F. M. Kok, Charles Honoré, Winan J. van Houdt   +4 more
doaj   +1 more source

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report

Case Reports in Oncology, 2022
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases.
Takuya Nakagawa, Yoshihide Kawasaki, Satoko Sato, Hiromichi Katayama, Yohei Satake, Shuichi Shimada, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka, Atsushi Kohyama, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Akihiro Ito   +14 more
doaj   +1 more source

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio, Biacchi, Daniele, Cardi, Maurizio, DI GIORGIO, Angelo, Mingarelli, Valentina, Musio, Daniela, Sammartino, Paolo, Sibio, Simone, Sollazzo, BIANCA MARIA   +8 more
core   +2 more sources

Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]

, 2019
Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica, Cardi, Maurizio, D'Agostino, Claudia, Fonsi, Giovanni Battista, Francesco Di Marzo,, Francesco, Lefoche, LA TORRE, Giuseppe, Sammartino, Paolo, Sibio, Simone   +8 more
core   +1 more source

Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer

Scientific Reports, 2021
The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these patients.
A. Llueca, M. Climent, J. Escrig, Paula Carrasco, A. Serra, L. R. G. V. A. K. K. M. N. C. A. I. C. J. P. E. A. R. Gomez-Quiles Játiva Cebrian Bosso Villarin Maiocch, L. Gómez-Quiles, R. Jativa, G. Cebrian, V. Bosso, A. Villarin, K. Maiocchi, K. Delgado-Barriga, M. Rodrigo-Aliaga, N. Ruiz, C. Herrero, A. Francés, I. Beato, C. Ferrer, J. P. Aracil, E. Boldo, A. Boldó, R. Adell   +22 more
semanticscholar   +1 more source

Cytoreductive Surgery for Advanced Ovarian Cancer [PDF]

Women's Health, 2014
The amount of the largest diameter of visible residual tumor after cytoreductive surgery remains one of the strongest prognostic factors In advanced ovarian cancer. The Implementation of a more aggressive surgical approach to Increase the proportion of patients without visible residual tumor Is, therefore, a rational concept.
Oliver Zivanovic, Dennis S. Chi, Martin Pölcher   +2 more
openaire   +2 more sources

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +2 more sources